The anti-neoplastic agents market is anticipated to reach USD 20,2263.4 Million by 2030 at 10.4% CAGR during the forecast period 2022-2030.
The anti-neoplastic agents market continues its upward trajectory, driven by rising cancer incidences worldwide and advancements in therapeutic modalities. With a compound annual growth rate (CAGR) projected to exceed 6% over the forecast period, the...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian